deoxyribonucleic acid (DNA) methylation in bone
cells and peripheral
blood cells, is promising for developments
Markelov, V.A.,
Korytina, G.F.,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N. Sh. (2024) , and KEAP1) genes was performed in peripheral
blood mononuclear
cells of COPD patients (n = 92) and control
Markelov, V.A.,
Korytina, G.F,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N Sh (2024) , and KEAP1) genes was performed in peripheral
blood mononuclear
cells of COPD patients (n = 92) and control
Melamud, Mark M.,
Bobrik, Daria V.,
Brit, Polina I.,
Efremov, Ilia S.,
Buneva, Valentina N.,
Nevinsky, Georgy A.,
Akhmetova, Elvina A.,
Asadullin, , Azat R.,
Ermakov, Evgeny A. (2024) biomarker analysis showed an increased white
blood cell count, and the elevated size and greater size
Zivari-Ghader, Tayebeh,
Valioglu, Ferzane,
Eftekhari, Aziz,
Aliyeva, Immi,
Beylerli, Ozal,
Davran, Soodabeh,
Cho, William C.,
Beilerli, Aferin,
Khalilov, Rovshan,
Javadov, Sabzali (2024) of conventional treatments for patients with central nervous system diseases. The
blood-brain barrier prevents
Beylerli, Ozal,
Gareev, Ilgiz,
Beilerli, Aferin,
Ilyasova, Tatiana,
Shi, Huaizhang,
Sufianov, Albert (2024) Astrocytes, the most prevalent
cells in the central nervous system, significantly contribute